This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatology  • Dermatologic Disorders  • Psoriasis  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the article by Voigtländer et al¹ concerning the efficacy of infliximab therapy for Sneddon-Wilkinson disease, as well as the more recent report by O'Quinn and Miller² of 2 cases of recalcitrant psoriasis that responded well to infliximab therapy. We would like to report our experience with infliximab-methotrexate combination therapy for severe pustular psoriasis of the palms and soles.

Report of a Case

A 70-year-old man presented with recalcitrant pustular psoriasis of the palms and soles that responded dramatically to monthly infusions of infliximab (Remicade; Centocor Inc, Malvern, Pa) at a dosage of 5 mg/kg but relapsed after 5 courses. The dosage was increased to 10 mg/kg, with an initial clearing of the lesions; however, after the second infusion, he again developed pustules. The addition of methotrexate sodium (7.5 mg/wk) to his regimen resulted in a complete response, with a lasting remission.

Over the 3 years before the initiation of infliximab-methotrexate . . . [Full Text of this Article]

Comment


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?